Warning Issued for Tymoutimol

The CIPCC issued a warning today for the popular treatment Tymoutimol. Hitting the market as a dietary supplement and thus without any testing from the CIFDA, Tymoutimol quickly caught on as a way to alleviate hallucinations involving Lucy Pyre. The Cringe Impyre Poison Control Center began taking samples of the drug after side effects were linked to its use. The CIPCC forwarded their findings to the CIFDA which did it’s own research.

After several accelerated trials the CIFDA now classifies the popular supplement as a drug regulated by the CIFDA and has forbidden it’s sale or distribution inside of the Cringe Impyre due to severe long term side-effects which ultimately cause pre-mature death. We reached out to the makers of Tymoutimol, the Multinational Oral Drug Syndicate, and they provided us with this statement.

“Outside of the Cringe Impyre the widespread use of Tymoutimol for Oshi related hallucinations has benefitted millions of users. The only place we’ve had trouble getting the drug approved for use is the Cringe Impyre. Only the Cringe Impyre reports any deleterious side-effects of our drug and multionational longitudinal studies from other sources conclude that Tymoutimol is safe enough to take while pregnant. MODS can only speculate about the discrepancy, but we’re prepared to challenge it in court.”